The Valley Desk

NCT07772024 · Interventional trial

Inobrodib, Pomalidomide and Dexamethasone Versus Standard Available Therapy in Relapsed or Refractory Multiple Myeloma

Overall registry status Recruiting

Phase 3

Conditions Multiple Myeloma Refractory, Multiple Myeloma in Relapse

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov